University of Maryland, Baltimore
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Maryland, Baltimore sits in the top decile of US sponsors by registered trial count (#62 of 15,742 sponsors by registered trial count).
University of Maryland, Baltimore: 560 sponsored US clinical trials, 103 recruiting.
University of Maryland, Baltimore sponsors 560 registered US clinical trials on ClinicalTrials.gov, 103 of them currently recruiting, and 332 completed. 77 of these trials are in Phase 3-4 (later-stage) and 161 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Schizophrenia, with 14 trials.
Top-decile sponsor footprint
University of Maryland, Baltimore ranks in the top decile of sponsors by registered trial count (#62 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
332 of 410 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (81.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
560 total, page 10 of 12
Safety and Efficacy Challenge Study of CVD 1208S, a Live, Attenuated Oral Vaccine to Prevent Shigella: Phase IIb
NCT00866242
Safety and Efficacy Study of CVD 1208S, a Live, Attenuated Oral Vaccine to Prevent Shigella Infection: Phase IIa
NCT00866476
Screening Protocol for Research Participants
NCT01010620
Maximal Bruce Protocol With the Use of Regadenoson For Myocardial Perfusion Stress Testing
NCT01026012
Examining Genetic Influence on Response to Beta-Blocker Medications in People With Type 2 Diabetes
NCT00925119
Dynamic Magnetic Resonance Imaging (MRI) for Lung Tumor Motion and Lung Function (GCC 0943)
NCT01016938
Salt Loading and Thiazide Intervention Study
NCT00896389
Effects of Oxytocin Nasal Spray on Social Affiliation
NCT00663039
Preoperative Accelerated Partial Breast Irradiation (APBI) for Women With Stage I and Select IIA Breast Cancer
NCT01014715
Nutrigenomics of Zinc Supplementation in Insulin Secretion and Diabetes
NCT00981448
Challenge! Adolescent Obesity Prevention
NCT03103269
An Integrated Approach to Smoking Cessation in Severe Mental Illness (SMI)
NCT00690131
Metabolic Causes of Thrombosis in Type 2 Diabetes Mellitus
NCT00829699
Class 3 Biowaivers
NCT01010698
Duloxetine for Treatment of Painful Temporomandibular Joint Disorder
NCT00981149
Mechanisms of Hypoglycemia Associated Autonomic Dysfunction, Q4-Atomoxetine
NCT00780650
Tacrolimus to Sirolimus Conversion for Delayed Graft Function
NCT00931255
Integrative Meditation (IM) for Cocaine Addiction
NCT01211418
Pharmacogenomics of Thiazolidinediones
NCT01135394
Simvastatin With or Without Ezetimibe and Atherothrombotic Biomarker Assessment
NCT00819403
Investigating the Improvement in 4D CT Images Using AV Biofeedback
NCT00780611
0822GCC: Phase 2 Study of Efficacy and Safety of Apricoxib/Placebo With Docetaxel or Pemetrexed in Non-Small Cell Lung Cancer
NCT00771953
Effects of Smoking Cues on Tobacco Craving Responses and the Reinforcing Efficacy of Cigarettes in Smokers With and Without Schizophrenia
NCT00770237
The Use of Oral Budesonide and Rectal Hydrocortisone for the Treatment of Active Ulcerative Colitis
NCT00805285
GlideScope Versus Direct Laryngoscope for Emergency Intubation
NCT01235065
0794GCC: Pentamidine in Treating Patients With Relapsed or Refractory Melanoma
NCT00729807
Prevention of Anthracycline or Trastuzumab Induced Cardiomyopathy by Metoprolol
NCT00806390
Gluten Free Diet in People With Schizophrenia: A Pilot Study
NCT01558557
Mobile Diabetes Management
NCT01107015
Biomarker Study of Acamprosate in Schizophrenia
NCT00688324
Side Effect Study of Antipsychotic Medicines to Treat Childhood Bipolar Disorder
NCT00746252
Myocardial Glucose Uptake (MGU) in Patients With Chronic Kidney Disease
NCT00883415
Bipolar and Schizophrenia Consortium for Parsing Intermediate Phenotypes
NCT00666432
Acupuncture in Reducing Muscle and Bone Symptoms in Women Receiving Letrozole, Exemestane, or Anastrozole for Stage 0, Stage I, Stage II, or Stage III Breast Cancer
NCT00641303
The Home Telemanagement (UC HAT) Trial for Patients With Ulcerative Colitis
NCT00620126
Water Immersion in Right-Sided Heart Failure: A Pilot Study
NCT00654264
Knowledge and Perception of Smoking Risks/Consequences
NCT00686101
The Effects of Rimonabant, on Weight and Metabolic Risk Factors
NCT00547118
A Self-Management Program for Adults With Both Schizophrenia and a Co-occurring Medical Condition
NCT00525304
Community-Based Care Management For Teen/Young Adult Mothers and Fathers
NCT00537108
Mechanisms of Hypoglycemia Associated Autonomic Dysfunction Question 2
NCT00574639
Mindfulness Intervention For Child Abuse Survivors (MICAS)
NCT00867802
Varenicline Adjunctive Treatment in Schizophrenia
NCT00492349
Metabolic Causes of Thrombosis in Type 2 Diabetes - Question 4
NCT00574340
Dose Escalation Study Of Chinese Herbs In Osteoarthritis Of The Knee
NCT00755326
Mechanisms of Ramipril Reduction in the Onset of Type 2 Diabetes
NCT00574834
Suspected Deficient Activation of Vitamin D in Patients With Secondary Hyperparathyroidism
NCT00754442
Safety of VSL#3 in Adult Asthmatics
NCT00852124
Rasagiline in the Treatment of Persistent Negative Symptoms of Schizophrenia
NCT00492336
Evaluation of Renal Drug Transport in Healthy Volunteers
NCT00690014
What is open in the University of Maryland, Baltimore pipeline
103 recruiting of 560 indexed (18% open); 332 completed (59%).
Phase mix: 77 late (III/IV) vs 161 early (I/II) (early-phase heavy).
Top condition: Schizophrenia (14 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Maryland, Baltimore: open-pipeline peers nationwide
Peers matched on 560 registered trials and 18% open enrollment, not the therapeutic-area sidebar.
University of Maryland, Baltimore sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 560 trials (± recruiting share)
- Amgen · 558 trials · 10% recruiting
- Merck Sharp & Dohme · 558 trials · 22% recruiting
- Virginia Commonwealth University · 558 trials · 14% recruiting
- National Institute of Neurological Disorders and Stroke (NINDS) · 567 trials · 8% recruiting
Sponsors near 18% open enrollment (± trial volume)
- Abramson Cancer Center at Penn Medicine · 18% recruiting · 402 trials
- Henry Ford Health System · 18% recruiting · 234 trials
- New York Institute of Technology · 18% recruiting · 49 trials
- University of California, San Diego · 18% recruiting · 775 trials
Related
What to do with this University of Maryland, Baltimore page
560 registered trials is a research-attention snapshot, not an endorsement of University of Maryland, Baltimore or any single study.
- 103 of University of Maryland, Baltimore's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Schizophrenia is the condition University of Maryland, Baltimore studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Schizophrenia trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Maryland, Baltimore pipeline card: 560 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.